Danaher (DHR) announced that Matthew Gugino, currently group CFO of the company’s Life Sciences Innovations Group and VP of Financial Planning & Analysis, will succeed Matthew McGrew as Danaher’s CFO effective February 28, 2026. Following the transition and consistent with past practice, McGrew will continue thereafter as an executive VP of the company, as he begins a gradual transition to retirement, after more than 20 years with Danaher.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHR: